Nanoparticles for accelerated drug development. Collaboration between global pharma and biotech to amplify the effectiveness of New Chemical Entities NCE
Location: Germany, Bavaria, Munich
Total raised: $20.513571M
Founded date: 2011
Investors 4
Date | Name | Website |
- | BayBG | baybg.de |
- | BayBG Vent... | baybg-vc.d... |
- | Signet Hea... | signetheal... |
- | TVM Capita... | tvm-lifesc... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
27.07.2015 | Series A | $20.513571... | - | finsmes.co... |
Mentions in press and media 9
Date | Title | Description | Category | Author | Source |
26.10.2022 | Harro Höfl... | LEON and Harro Höfliger to bui... | - | - | globenewsw... |
16.04.2020 | leon-nanod... | leon-nanodrugs GmbH, a Munich,... | Germany | - | finsmes.co... |
09.01.2017 | leon Appoi... | leon nanodrugs GmbH appoints p... | - | - | signetheal... |
09.01.2017 | leon Appoi... | leon nanodrugs GmbH appoints p... | - | - | tvm-lifesc... |
17.08.2015 | Leon-nanod... | TVM Capital Life Science leads... | - | - | signetheal... |
29.07.2015 | Munich´s l... | leon nanodrugs GmbH today anno... | - | - | bio-m.org/... |
27.07.2015 | leon nanod... | leon nanodrugs GmbH, a Munich,... | Germany | - | finsmes.co... |
27.07.2015 | Daily fund... | Palantir received $450M; Draft... | - | Mitos Suso... | vator.tv/n... |
27.07.2015 | leon-nanod... | TVM Capital Life Science leads... | - | - | tvm-lifesc... |